Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Orthopediatrics Corp (NQ: KIDS )

27.36 -0.28 (-1.01%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 77,276
Open 27.60
Bid (Size) 26.95 (1)
Ask (Size) 27.74 (1)
Prev. Close 27.64
Today's Range 27.29 - 28.18
52wk Range 23.10 - 38.99
Shares Outstanding 19,672,616
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
KIDS Stock Earnings: OrthoPediatrics Beats EPS, Beats Revenue for Q2 2024
KIDS stock results show that OrthoPediatrics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
OrthoPediatrics Corp. Reports Second Quarter 2024 Financial Results and Reaffirms Full Year 2024 Revenue Guidance
Record Second Quarter 2024 Revenue Increased 33% Year-over-Year 
From OrthoPediatrics Corp.
Via GlobeNewswire

Performance

YTD
-17.12%
-17.12%
1 Month
-22.69%
-22.69%
3 Month
-14.55%
-14.55%
6 Month
-7.13%
-7.13%
1 Year
-28.26%
-28.26%

More News

Read More
OrthoPediatrics Corp. Announces Private Financing
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Report Second Quarter 2024 Financial Results on August 6, 2024
From OrthoPediatrics Corp.
Via GlobeNewswire
Expert Ratings For OrthoPediatrics
Via Benzinga
The Analyst Verdict: OrthoPediatrics In The Eyes Of 6 Experts
Via Benzinga
OrthoPediatrics Corp. to Participate in the Truist Securities MedTech Conference
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Continued Leading Sponsorship at 2024 EPOSNA Annual Meeting
From OrthoPediatrics Corp.
Via GlobeNewswire
KIDS Stock Earnings: OrthoPediatrics Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
OrthoPediatrics Corp. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance
From OrthoPediatrics Corp.
Via GlobeNewswire
Cracking The Code: Understanding Analyst Reviews For OrthoPediatrics
Via Benzinga
Recap: OrthoPediatrics Q4 Earnings
Via Benzinga
OrthoPediatrics Corp. Receives “Breakthrough Device” Designation from FDA for eLLi™ Growing Rod System for Pediatric Patients with Scoliosis
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Report First Quarter 2024 Financial Results on May 7, 2024
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 8th Annual International Children’s Spine Symposium (ICSS)
From OrthoPediatrics Corp.
Via GlobeNewswire
Earnings Outlook For OrthoPediatrics
Via Benzinga
Decoding 5 Analyst Evaluations For OrthoPediatrics
Via Benzinga
OrthoPediatrics Corp. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
From OrthoPediatrics Corp.
Via GlobeNewswire
American Eagle Reports Upbeat Earnings, Joins Kroger, Burlington Stores And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Topics Stocks
Exposures US Equities
KIDS Stock Earnings: OrthoPediatrics Beats EPS, Misses Revenue for Q4 2023
Via InvestorPlace
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Launches New RESPONSE Rib and Pelvic Fixation System for EOS Scoliosis
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Named One of the 2024 Best Places to Work in Indiana
From OrthoPediatrics Corp.
Via GlobeNewswire
Earnings Scheduled For March 6, 2024
Via Benzinga
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024
From OrthoPediatrics Corp.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.